Survival Rate for Advanced-stage Prostate Cancer Patients with Surgery
Author: Mayo Clinic
Synopsis and Key Points:
Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery.
Main DigestAdvanced-stage prostate cancer patients experience 20-year survival rates with surgery.
Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found.
Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland. Previously, patients found to have cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy.
The researchers presented their findings during the American Urological Association Annual Meeting in Washington.
"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," says R. Jeffrey Karnes, M.D., of Mayo Clinic's Department of Urology. "We have confirmed that patients diagnosed with locally advanced prostate cancer can enjoy a long, cancer-free interval."
The 80 percent survival rate for cT3 diagnoses at 20 years compares to 90 percent for cT2, or cancer confined to the prostate.
This long-term follow-up of patients who underwent surgery between 1987 and 1997 is an important advance in understanding the quality outcomes for cT3 patients.
The study sample included patients diagnosed and operated on between 1987 and 1997. Ongoing research will examine contemporary data.
Other study investigators include Christopher Mitchell, M.D., Eric Umbreit, M.D., Rachel Carlson and Laureano Rangel, all of Mayo Clinic.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.org/about/ and www.mayoclinic.org/news.
- 1 - Male Prostate Exam: PSA, DRE and PVR Tests : Dr. David Samadi (2015/10/30)
- 2 - Genetic Testing Identifies Males at Risk of Prostate Cancer : Institute of Cancer Research (2014/09/15)
- 3 - Digital Rectal Exam Vs. PSA Test For Prostate Cancer : Dr. David Samadi Prostate Cancer Center (2016/09/27)
- 4 - Urine Test for Prostate Cancer : RoboticOncology.com (2011/08/14)
- 5 - Prostate MRI Reveals More Treatable Cancers and Reduces Overdiagnosis : European Association of Urology (2018/03/19)
- 6 - Male Prostate Specific Antigen (PSA) Levels and Chart : Disabled World (2015/02/14)
- 7 - Noscapine for Prostate Cancer : MedInsight Research Institute (2010/03/19)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
• Please report outdated or inaccurate information to us.